Genentech’s drug Avastin is used to treat cancer, but has also been used off-label for treatment of eye disease including diabetic retinopathy (DR). Sam Grossman discusses some of the studies’ findings of this medicine and whether people with DR may want to inquire with their healthcare providers about it.
Certified diabetes educator Amy Hess-Fischl talks about using GLP-1 agonists off-label in people with type 1 and shares some anecdotal evidence from patients as well as studies using this drug class in this patient population.
The Prevent Diabetes STAT: Screen, Test, Act–Today initiative and National Diabetes Prevention Program (NDPP) Lifestyle Change Programs are essential to stem the rising tide of diabetes.
An FDA Panel recommends new safety information on DPP-4 inhibitors Onglyza and Nesina. Sam Grossman reviews this news and how it may affect marketing and prescribing of the medications.
Sanofi’s recently approved insulin, Toujeo, is 300u/ml and offers clinicians and people with diabetes who have glycemic control issues another long-acting insulin. Sam Grossman discusses some of the studies’ findings.
White, brown, and wild are all options most of us love. For some, rice can be the ultimate trigger food.
This blog will explore the ins and outs of magnesium. Why we need it, how much we need, foods high in magnesium, medications that affect magnesium status and what the research is showing about the relationship it has to diabetes. Â
The Dario glucose meter provides high functionality and numerous features to help make the life of people with diabetes easier. Andrew Stivelman reviews this high tech device and app and offers instructions into how to use them.
Mary Rechtoris talks about resisting the urge to scold people about their sometimes hurtful comments about diabetes and taking their lack of knowledge about the disease and educating them to provide them with a better understanding.
Certified diabetes educator Amy Hess-Fischl offers some guidance in determining how to incorporate a healthier diet.
Certified diabetes educator Megan Day provides an overview of these types of insulin, mechanisms of action, and who are candidates for these medicines.
The FDA recently approved Lucentis for use of diabetic retinopathy. Pharmacist and certified diabetes educator Sam Grossman talks about the clinical trial results for the new drug and considerations of how people with the complication may want to consider talking to their provider about it.
I have helped many children with diabetes over the span of my career. Incidence of type 2 diabetes among children is increasing with time.
Diabetes educator Debbie Berg discusses some strategies to make it easier to keep up with your regular regimen of medicine.
Why is it important to keep your blood glucose under control? For one, it help reduce your chance for complications. Find out more.